Xiu-Li Wu

Xiu-Li Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiu-Li Wu has a total of 110 co-authors. Here are the top co-authors by number of shared publications:

  • Cheng Liu

    College of Pharmacy Key Laboratory of Protection Development and Utilization of Medicinal Resources in Liupanshan Area Ministry of Education Ningxia Medical University Yinchuan 750004 P.R. China

    5 shared publications
  • Hong-Yan Ji

    Department of Pharmaceutics, General Hospital of Ningxia Medical University, Yinchuan 750004, PR China

    3 shared publications
  • Jie Chen

    School of Pharmacy, Ningxia Medical University, Yinchuan, China

    3 shared publications
  • Jing Chen

    3 shared publications
  • Li Zhou

    College of Pharmacy Key Laboratory of Protection Development and Utilization of Medicinal Resources in Liupanshan Area Ministry of Education Ningxia Medical University Yinchuan 750004 P.R. China

    3 shared publications
  • Zhi-Bo Jiang

    School of Chemistry and Chemical Engineering, Key Laboratory for Chemical Engineering and Technology of State Ethnic Affairs Commission North Minzu University Yinchuan People's Republic of China

    3 shared publications

Latest Publications

  • Open Access

    In Vivo Absorption of Iron Complexes of Chondroitin Sulfates with Different Molecular Weights and Their Anti-Inflammation and Metabolism Regulation Effects on LPS-Induced Macrophages

    by Qianqian Du, Jiachen Zheng, Fanhua Kong, Xiuli Wu, Chunqing Ai, Shuang Song

    The present study investigated the effects of hierarchical molecular weights and iron chelation on the in vivo absorption and the inflammatory bioactivity of chondroitin sulfate (CS). Firstly, CS, chondroitin sulfate-iron complex (CS-Fe), and low-molecular-weight chondroitin sulfate-iron complex (LCS-Fe) were fluorescently labeled and characterized. Then, the plasma concentration–time profiles and fluorescence imaging results demonstrated that LCS-Fe was more efficiently absorbed into the bloodstream and showed a higher Cmax (415.16 ± 109.50 μg/mL) than CS-Fe (376.60 ± 214.10 μg/mL) and CS (135.27 ± 236.82 μg/mL), and it clearly accumulated in the liver. Furthermore, the anti-inflammatory effect of CS-Fe and LCS-Fe was assayed in LPS-induced macrophages, and LCS-Fe and CS-Fe both showed a better inhibitory effect on NO production, COX-2 and IL-1β gene expression levels compared to CS. Additionally, targeted metabolic analysis of macrophages using LC-MS/MS revealed that CS, CS-Fe, and LCS-Fe could reverse approximately one quarter of the LPS-induced differential metabolites, and the biosynthesis of valine, leucine, and isoleucine was the most significantly involved metabolic pathway. Notably, the molecular weight reduction and iron chelation could both enhance the bioavailability and anti-inflammatory efficacy of CS.


  • Open Access

    Functional Characterization of an Aldol Condensation Synthase PheG for the Formation of Hispidin from Phellinus Igniarius

    by Wanting Zhang, Ruliang Zheng, Weiling Geng, Xinyuan Wu, Xiaojuan Gao, Li Zhou, Zhenyu An, Cheng Liu, Zhijun Song, Hongyan Ji, et al.

    Hispidin ( 1 ) is a polyphenolic compound with a wide range of pharmacological activities that is distributed in both plants and fungi. In addition to natural extraction, hispidin can be obtained by chemical or enzymatic synthesis. In this study, the identification and characterization of an undescribed enzyme, PheG, from Phellinus igniarius ( P. igniarius ), which catalyzes the construction of a key C─C bond in the enzymatic synthesis of hispidin are reported. It is demonstrated in vitro that PheG generates hispidin by catalyzing C─C bond formation in the aldol condensation reaction. Based on these results, a plausible pathway for hispidin biosynthesis is proposed by utilizing the primary triacetic acid lactone (TAL, 2 ) and 3,4‐dihydroxybenzaldehyde ( 3 ). The mechanisms for the aldol condensation reaction of PheG are investigated using molecular dynamics (MD) simulations, molecular mechanics/generalized Born surface area (MM/GBSA) binding free energy calculations, density functional theory, and site‐specific mutations. The locations of the key amino acid residues that catalyze the conversion of substrates 2 and 3 to hispidin at the active site of PheG‐1 are identified. This study provides a new method for preparing hispidin with high efficiency and low cost.


  • Biodegradation of imidacloprid and diuron by Simplicillium sp. QHSH-33

    by Ke Xu, Xin-Ran Ke, Wan-Ting Zhang, Xin-Yuan Wu, Zhi-Jun Song, Mei-Juan Jiao, Xiao-Juan Gao, Li Zhou, Hong-Yan Ji, Fang Wang, et al.


  • Secondary Metabolite Analysis of Phomopsis sp. LGT‐5 Based on the Dual Guidance of Whole‐Genome Sequencing and HPLC‐Q‐ToF‐MS/MS

    by Jia‐Jia Zhu, Na Xi, Cheng Liu, Ping‐Yang Ma, Xin‐Yuan Wu, Li Zhou, Zhen‐Yu An, Zhi‐Bo Jiang, Xiu‐Li Wu, Jian‐Huan Wang

    Microorganisms produce a wealth of structurally diverse specialized metabolites with a remarkable range of biological activities. The Phomopsis sp. LGT‐5 was obtained through tissue block and repeatedly crossed methods from Tripterygium wilfordii Hook. F. The antibacterial experiments of LGT‐5 showed that it has high inhibitory activity against Staphylococcus aureus and Pseudomonas aeruginosa, and moderate inhibitory activity against Candida albicans. To research the generation of the antibacterial phenomenon of LGT‐5 and provide support for further research and application, the whole genome sequencing (WGS) of LGT‐5 was obtained by single‐molecule real‐time DNA sequencing platform Pacific Biosciences (PacBio) sequencing and Illumina paired‐end sequencing. The final assembled LGT‐5 genome is 54.79 Mb with a contig N50 of 290.07 kb; in addition, its secondary metabolites were detected through HPLC‐Q‐ToF‐MS/MS. By comparing its MS/MS data, the secondary metabolites were analyzed based on visual network maps obtained on the Global Natural Products Social Molecular Networking (GNPS). The analysis results showed that the secondary metabolites of LGT‐5 were triterpenes and various cyclic dipeptides.


  • Seven lower toxicity celastrol derivatives by biotransformation of Pestalotiopsis sp. LGT-1

    by Senyu Zhang, Lumei Liu, Bangwen Yue, Xinyuan Wu, Hongyan Ji, Jianhuan Wang, Zhibo Jiang, Cheng Liu, Xiuli Wu


  • Open Access

    Native Endophytes of Tripterygium wilfordii-Mediated Biotransformation Reduces Toxicity of Celastrol

    by Ping-Yang Ma, Wei-Ling Geng, Hong-Yan Ji, Bang-Wen Yue, Cheng Liu, Sa Wang, Zhi-Bo Jiang, Jing Chen, Xiu-Li Wu

    Celastrol (1), obtained from the roots of Tripterygium wilfordii Hook F., is most likely to become an antitumor drug, but with severe cytotoxicity. Due to the lack of modifiable sites in the structure of celastrol, the structural diversity of the modified products obtained by synthesis in the previous studies is insufficient, which hinders the pace of its patent medicine. This study describes a method of microbial transformation to increase the modification site of celastrol and reduce its toxicity. The screening of endophytes from native plants was introduced in this context, which led to two novel stereoselective oxidation products such as S-16-hydroxyl celastrol (2) and A-ring aromatized S-16-hydroxyl celastrol (3), along with a rare 7,9-octadecadienoic acid ester of celastrol (4). Their structures were determined by extensive spectroscopic data analysis, especially 1D and 2D NMR. Compared with 1, compounds 3 and 4 exhibited similar antitumor activity in U251, A549, KG-1, and B16 cell lines. Compound 2 had slightly decreased antitumor activity when compared with compound 1. Furthermore, compound 2–4 showed lower cytotoxicity against BV-2 (about 21-fold lower, 2: 92.82 μM, 3: 34.25 μM, and 4: 74.75 μM vs. celastrol: 4.35 μM), and also identical trends against H9c2 and PC12 cell lines.


  • Classification of diterpenoid alkaloids from Aconitum kusnezoffii Reichb. by liquid chromatography‐tandem mass spectrometry‐based on molecular networking

    by Zhi‐Bo Jiang, Huan‐Huan Guo, Yun‐Qi Hu, Le‐Rui Zhou, Chao‐Fan Deng, Ze‐Dong Nan, Xiao‐Li Ma, Xiu‐Li Wu

    Trace amounts of components in traditional Chinese medicine are considered pharmacological active substances used for treating many serious diseases. However, purifying all the trace substances and making clear their structures are not easy. In this context, high‐performance liquid chromatography coupled with quadrupole time‐of‐flight tandem mass spectrometry based molecular networking was applied to investigate the chemical constituents of the roots of Aconitum kusnezoffii Reichb., which led to the identification of 33 nodes in different groups (N1–N33). Based on the excremental fragmentation pathway of known diterpenoid alkaloids (1–9) and comparisons of characteristic ions and characteristic loss of analogs in literature, the structures of unknown ions were deduced. This work lays a foundation for the evaluation of the clinical basis and mechanism of traditional Chinese medicine from the aspects of chemistry. In this paper, the method speculation of unknown natural products by means of molecular network method is expected to be applied in the discovery and change law of relevant active components in clinical pharmacology and the change of complex systems caused by trace active compounds.


  • Open Access

    Identification of active chemical constituents of Asplenium ruprechtii Sa. Kurata based on in vitro neuroprotective activity evaluation

    by Zhi-Bo Jiang, Xing Lu, Jing-Zhi Chen, Xiao-Li Ma, Yi-Hu Ke, Xin Guo, Hai Liu, Chong-Long Li, Fang Wang, Xiu-Li Wu, et al.

    Mining structural novel and bioactive natural products from traditional Chinese drugs and folk medicines have attracted attention from pharmacologists and pharmaceutical chemists for a long time. In this study, the chemical constituents of Asplenium ruprechtii Sa. Kurata was systematically studied based on the evaluation of neuroprotective activity on hydrogen peroxide (H2O2)-induced damage of SH-SY5Y cell lines. Sixteen chemical monomers (1–16), including two new structures of 9,19-cycloartane-triterpenoid saponins (1,2), were discovered. Their chemical structures were established based on extensive spectroscopic data analysis, including the one- and two-dimensional (1D and 2D) nuclear magnetic resonance (NMR) data and high-resolution electrospray ionization mass spectrometry (HRESIMS). All monomer compounds were docked with an “active pocket” at the N-terminal of the GluN2B protein, where compounds 13–16 were found to possess high binding scores, which warrant further study on the molecular mechanism. Our findings provide insight and research techniques for discovering new drugs based on neuroprotective activity.


  • Structural determination and in vitro tumor cytotoxicity evaluation of five new cycloartane glycosides from Asplenium ruprechtii Sa. Kurata

    by Fang Wang, Zhi-Bo Jiang, Xiu-Li Wu, Da-Lian Liang, Ning Zhang, Min Li, Lei Shi, Chong-Gang Duan, Xiao-Li Ma, Dai-Zhou Zhang